How can healthcare companies capitalise on digital initiatives and improve patient experiences In June 2020, the Capgemini Research Institute conducted a survey of more than 2,000 consumers in France, Germany, the United…
DCGI approves Biocon’s Itolizumab drug for COVID 19 patients with CRS and ARDS (ALZUMAb) Injection 25mg/5mL solution is for emergency use only and for the treatment of cytokine release syndrome (CRS) in…
